Prophylaxis strategies for contrast-induced nephropathy

Area of Science:

• Nephrology
• Radiology
• Cardiology

Background:

• Contrast-induced nephropathy (CIN) leads to severe clinical and economic burdens, including extended hospital stays, dialysis, and mortality.
• Identifying and mitigating CIN risk is crucial for patient outcomes and healthcare costs.

Purpose of the Study:

• To review evidence on preventing contrast-induced nephropathy (CIN).
• To provide recommendations for managing high-risk patients undergoing angiographic procedures.
• To highlight areas for future research in CIN prophylaxis.

Main Methods:

• Systematic literature searches of MEDLINE, EMBASE, and Cochrane databases (1966-2006).
• Included observational studies on risk factors and randomized controlled trials (RCTs) of prophylaxis strategies for CIN.
• Defined CIN or postprocedure creatinine levels as outcome measures.

Main Results:

• Key patient risk factors for CIN include chronic kidney disease, diabetes, heart failure, and older age.
• High-osmolar, ionic contrast media, and increased contrast volume are non-patient-related risks.
• Evidence supports hydration, bicarbonate, and low-osmolar contrast for CIN prevention; N-acetylcysteine or ascorbic acid may benefit very high-risk individuals.

Conclusions:

• Despite identified risk factors, effective CIN prophylaxis is hindered by incomplete understanding of its pathophysiology and clinical impact.
• Future research must prioritize accurate identification of high-risk patients and conduct large, well-powered clinical trials to test therapies.